Home
Novacap

Novacap Market Share Analysis for July 2026

seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients with 24 manufacturing sites and 7 r&d centers in europe, north america and asia.

Heavy Industry and Engineering > Chemical Industry

Domainnovacap.eu

Year Founded2003

Employees1001 - 5000

Annual Revenue$500M - $1B

Novacap

Novacap (including company regionals)

novacap.eu

See more website traffic and engagement information

Novacap Revenue up to July 2026 is 500M - 1B

revenue generated by Novacap top domains

Novacap top domains revenue over 3 years

Revenue for Novacap top domains

novacap.eu500M - 1B

See more with Sales Intelligence

Total visits to Novacap's top domains

Understand Novacap market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Novacap's top domains

Analyze Novacap engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Novacap's top domains

See how Novacap keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Novacap top competitors by domain

Top similar sites in July 2026, ranked by their affinity

penrice.com.auCompany NamePenrice Soda HoldingsEmployees51 - 200HQAustralia, OsborneAnnual revenue$10M - $15MTotal visits--Heavy Industry and Engineering > Chemical Industry

Top technologies used by Novacap

These are the website technologies, by industry, used by Novacap top domains

Widget (3)

reCAPTCHA

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

Online Forms (2)

Gravity Forms

More Technologies

6

See all

News & Signals from Novacap

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovacap acquired Pcisynthesis on Jun 20th '18.Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO), further reinforcing Novacap’s capabilities and offering for the pharmaceutical industry.